Company intelligence / Profile preview

Biofarm Biotechnology

Breda, Catalonia, Spainbiofarm.cat ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

Biofarm Biotechnology manufactures autogenous vaccines for production animals. These are custom-made vaccines developed from pathogens isolated from a specific farm or herd, providing targeted disease prevention. The company emphasizes safety and sterility in its manufacturing process and serves the animal health sector with a focus on livestock disease management. No clinical trial data is available as these are veterinary products regulated differently than human medicines.

Therapeutic areas: Infectious Diseases
Modalities: VaccineAutogenous vaccine
Industry: Veterinary

Beyond the preview

Go deeper on Biofarm Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biofarm Biotechnology.

Explore the full profile